| Analysis | Metabolite Name | Measured Value | Units | Group | TIMEPOINT |
|---|---|---|---|---|---|
| HILIC NEGATIVE ION MODE | myo-inositol | 0.5103 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.5933 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.5949 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.6051 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.6135 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.6206 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.6427 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.6470 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.6547 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.6640 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.6778 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.6786 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7119 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7184 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7191 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7217 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7257 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7309 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7309 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7319 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7398 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7424 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7445 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7461 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7496 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7506 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7694 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7730 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7779 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7788 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7804 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7870 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7905 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7928 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.7947 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8041 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8107 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8125 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8186 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8193 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8268 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8300 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8324 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8344 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8353 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8422 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8532 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8609 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8636 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8636 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8641 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8656 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8688 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8730 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8751 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8785 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8786 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8792 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8825 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8899 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8934 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8949 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8955 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.8966 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9001 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9039 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9058 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9092 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9169 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9183 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9188 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9193 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9253 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9320 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9327 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9381 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9422 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9436 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9488 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9510 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9517 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9553 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9578 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9641 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9690 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9713 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9718 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9737 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9740 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9816 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9856 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9896 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 0.9998 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0000 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0002 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0014 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0031 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0034 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0065 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0079 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0101 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0107 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0126 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0260 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0278 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0389 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0395 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0481 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0621 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0770 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0773 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0789 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0832 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0850 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.0960 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1028 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1101 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1110 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1125 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1139 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1245 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1312 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1382 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1389 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1405 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1431 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1496 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1556 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1645 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1646 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1723 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1766 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1818 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1855 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1882 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.1941 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.2104 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.2154 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.2196 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.2320 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.2441 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.2467 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.2622 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.2667 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.2817 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.2881 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.2901 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.2949 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.2958 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.2960 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.3378 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.3544 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.3600 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.3615 | scaled units | Placebo | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.3695 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.3708 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.3775 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.3872 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.4313 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.4552 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.4645 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.4822 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.4875 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.5218 | scaled units | High-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.5362 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.6280 | scaled units | High-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.6570 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.7235 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.7432 | scaled units | Placebo | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.7739 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.8023 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.8957 | scaled units | Low-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.9061 | scaled units | Placebo | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 1.9415 | scaled units | Low-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 2.2051 | scaled units | High-Dose | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 2.2524 | scaled units | High-Dose | +23HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 2.2555 | scaled units | Placebo | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 2.2769 | scaled units | High-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 2.2803 | scaled units | Placebo | +47HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 2.3055 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 2.3121 | scaled units | Low-Dose | BASELINE |
| HILIC NEGATIVE ION MODE | myo-inositol | 2.4227 | scaled units | High-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 2.4337 | scaled units | Low-Dose | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 2.4819 | scaled units | Placebo | +4HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 2.5406 | scaled units | Low-Dose | -0.5HR |
| HILIC NEGATIVE ION MODE | myo-inositol | 2.7806 | scaled units | Low-Dose | +71HR POST INFUSION |
| HILIC NEGATIVE ION MODE | myo-inositol | 2.8444 | scaled units | Low-Dose | BASELINE |
- UCSD Metabolomics Workbench, a resource sponsored by the Common Fund of the National Institutes of Health
|